Severe CMV complication following maintenance therapy with rituximab

11Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Cytomegalovirus (CMV) encephalitis is a rare infection that immunodeficient patients, mainly where HIV-positive, may suffer from. Several cases were described when complications with the treatment with monoclonal antibodies, like rituximab, for malignant lymphomas. We will describe here the case of a patient, who has developed CMV gastritis, then CMV encephalitis after the treatment of a CLL with a chemotherapy and maintenance therapy with rituximab. Copyright 2013 BMJ Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Le Clech, L., Ianotto, J. C., Quintin-Roue, I., & Tempescul, A. (2013). Severe CMV complication following maintenance therapy with rituximab. BMJ Case Reports. https://doi.org/10.1136/bcr-2012-006672

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free